SEGALL BRYANT & HAMILL, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 104 filers reported holding TG THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$241,000
-7.3%
5,0000.0%0.00%
-33.3%
Q4 2020$260,000
-48.1%
5,000
-91.8%
0.00%
-72.7%
Q4 2017$501,000
-21.1%
61,092
+14.0%
0.01%
-26.7%
Q3 2017$635,000
+17.8%
53,5920.0%0.02%
+15.4%
Q2 2017$539,000
+1.7%
53,592
+17.8%
0.01%0.0%
Q1 2017$530,000
+636.1%
45,500
+193.5%
0.01%
+550.0%
Q4 2016$72,00015,5000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders